Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Caris Life Sciences (CAI) FCF Margin (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of FCF Margin data on record, last reported at 18.27% in Q4 2025.

  • For Q4 2025, FCF Margin rose 4507.0% year-over-year to 18.27%; the TTM value through Dec 2025 reached 12.53%, changed N/A, while the annual FY2025 figure was 9.94%, 6991.0% up from the prior year.
  • FCF Margin reached 18.27% in Q4 2025 per CAI's latest filing, up from 409.64% in the prior quarter.
  • Across five years, FCF Margin topped out at 18.27% in Q4 2025 and bottomed at 409.64% in Q3 2025.